← All trials
NCT05765084
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 24, 2023
- Primary completion
- Oct 31, 2026
- Completion date
- Oct 31, 2026
- First posted
- Mar 13, 2023
- Last posted
- Nov 9, 2023
- Enrollment
- 15
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of AntwerpLead sponsor
- Algemeen Ziekenhuis Maria MiddelaresCollaborator
- University of AntwerpStudy director
- Kom Op Tegen KankerCollaborator
- RocheCollaborator
- University of AntwerpOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.